Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan | Zendy

Wenyu Ye | Zendy; Haya AscherSvanum | Zendy; Tanji | Zendy; Flynn | Zendy; Takahashi | Zendy

Open Access

Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan

Author(s) -

Wenyu Ye,

Haya AscherSvanum,

Tanji,

Flynn,

Takahashi

Publication year - 2011

Publication title -

patient preference and adherence

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.885

H-Index - 48

ISSN - 1177-889X

DOI - 10.2147/ppa.s26002

Subject(s) - olanzapine , medicine , discontinuation , schizophrenia (object oriented programming) , quality of life (healthcare) , observational study , logistic regression , psychiatry , nursing

Treatment continuation is considered an important measure of antipsychotic effectiveness in schizophrenia, reflecting the medication's efficacy, safety, and tolerability from both patients' and clinicians' perspectives. This study identified characteristics of patients with schizophrenia who continue olanzapine therapy for a 1-year period in Japan.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research